Leadership & Pay ·
On July 22, 2026, the Board of Directors approved the appointment of Dr. Sridevi Khambhampaty as Global Head of…
RDYDR Reddys Laboratories Ltd
On July 22, 2026, the Board of Directors approved the appointment of Dr. Sridevi Khambhampaty as Global Head of Biologics, Senior Management Personnel, and Member of the Management Council. Additionally, the Board appointed M/s Deloitte Haskins & Sells, LLP as the company's Independent Registered Public Accounting Firm to audit financial statements for Form 20-F and review interim statements for Form 6-K, aligning with their previous appointment as Statutory Auditors for a five-year term. The company operates in the pharmaceutical industry and develops generic medicines and biologics.